montenegro, bosnia and herzegovina, cyprus, united kingdom, albania, malta, ireland, macedonia, spain, moldova, france, germany, san marino, switzerland, poland, netherland, hungary, italy, belgium, austria, greece, russia, sweden, norway, portugal, romania, serbia, bulgaria, czech republic, latvia, lithuania, slovakia, slovenia, ukraine, andorra, kosovo, liechtenstein, finland, monaco, vatican, belarus, denmark, estonia, luxembourg, iceland
27 Feb 2026 06:31
Ipsen Receives Positive CHMP Opinion For Ojemda® For The Treatment As Monotherapy Of Children With Relapsed Or Refractory BRAF-Altered Pediatric Low-Grade Glioma (menafn)
(MENAFN - GlobeNewsWire - Nasdaq) If approved, Ojemda– (tovorafenib) is expected to be the first and...